J.K. Joung, et al. TALENs: a widely applicable technology for targeted genome editing. Nature Reviews Molecular Cell Biology. 2013 Jan. doi:10.1038/nrm3486.

Aug

30

Editas Medicine Announces Upcoming Investor Events

Aug

2

Editas Medicine Announces Second Quarter 2023 Results and Business Updates

Jul

27

Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization